Literature DB >> 8993838

Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.

V Giandomenico1, F Lancillotti, G Fiorucci, Z A Percario, R Rivabene, W Malorni, E Affabris, G Romeo.   

Abstract

Both retinoids and IFNs are known to inhibit proliferation of many normal and transformed cells and to have an in vivo antitumor effect against a variety of cancers, including squamous cell carcinoma. Because the combination of IFNs and all-trans retinoic acid (RA) could improve their antitumor effectiveness (depending on the histological origin and state of differentiation of the cells), we compared the activity of RA and/or IFN-alpha 2b with regard to the mechanism of growth inhibition of ME180 and SiHa cell lines, derived from squamous cervix carcinoma at different stages of differentiation. We reported previously that, in the ME180 cell line, the combined treatment significantly increased the growth inhibitory effect of the single agents. Here, we show that the SiHa cell line appears more sensitive to IFN-alpha 2b than the ME180 cell line, and resistant to RA, which does not significantly inhibit SiHa cell growth. Induction of apoptotic cell death clearly occurs and correlates with the inhibition of cell proliferation in both cell lines. It is interesting that the induction of the transcription factor IFN regulatory factor 1 correlates with the subsequent induction of apoptosis, whereas TGase I and II expression does not. In particular, TGase I and II appear differentially expressed in the ME180 and SiHa cell lines; i.e., TGase I is expressed in ME180 and specifically inhibited by RA, whereas TGase II is expressed in SiHa. It is interesting that both IFN-alpha and RA are able to increase TGase II expression and activity in this cell line.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993838

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells.

Authors:  Carla Esposito; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; Raffaele Porta; Anna Cozzolino; Michele Caraglia; Alberto Abbruzzese
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo.

Authors:  Jie-Ping Chen; Chen Lin; Cai-Pu Xu; Xue-Yan Zhang; Ming Wu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.

Authors:  Michaele J Armstrong; Michael T Stang; Ye Liu; Jin Yan; Eva Pizzoferrato; John H Yim
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Growth arrest of epithelial cells during measles virus infection is caused by upregulation of interferon regulatory factor 1.

Authors:  Shin-ichi Yokota; Tamaki Okabayashi; Noriko Yokosawa; Nobuhiro Fujii
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells.

Authors:  Istvan Arany; William E Whitehead; Kenneth J Grattendick; Istvan A Ember; Stephen K Tyring
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.

Authors:  T Brodowicz; C Wiltschke; D Kandioler-Eckersberger; T W Grunt; M Rudas; S M Schneider; M Hejna; A Budinsky; C C Zielinski
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Might Routine Vitamin A Monitoring in Cystic Fibrosis Patients Reduce Virus-Mediated Lung Pathology?

Authors:  Robert E Sealy; Sherri L Surman; Peter Vogel; Julia L Hurwitz
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.